President Trump announced new agreements with U.S. and international pharmaceutical firms to lower drug prices. Major companies including Pfizer, AstraZeneca, Eli Lilly, and Novo Nordisk have committed to voluntary price reductions. Trump also warned of tariffs on Europe and the UK if they refuse to lower pharmaceutical prices for the U.S.